Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0007 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |